Medlive Technology Balance Sheet Health
Financial Health criteria checks 6/6
Medlive Technology has a total shareholder equity of CN¥4.9B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥5.1B and CN¥213.8M respectively. Medlive Technology's EBIT is CN¥131.3M making its interest coverage ratio -0.7. It has cash and short-term investments of CN¥3.6B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -0.7x |
| Cash | CN¥3.62b |
| Equity | CN¥4.90b |
| Total liabilities | CN¥213.84m |
| Total assets | CN¥5.11b |
Recent financial health updates
Recent updates
Does Medlive Technology (HKG:2192) Deserve A Spot On Your Watchlist?
Feb 03
Medlive Technology Co., Ltd.'s (HKG:2192) 30% Price Boost Is Out Of Tune With Earnings
Jan 12Medlive Technology Co., Ltd. (HKG:2192) Shares Could Be 33% Above Their Intrinsic Value Estimate
Jan 09Medlive Technology (HKG:2192) Ticks All The Boxes When It Comes To Earnings Growth
Oct 27There's Reason For Concern Over Medlive Technology Co., Ltd.'s (HKG:2192) Price
Sep 23Returns On Capital At Medlive Technology (HKG:2192) Paint A Concerning Picture
Aug 06Medlive Technology Co., Ltd. (HKG:2192) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Jun 22What Medlive Technology Co., Ltd.'s (HKG:2192) 25% Share Price Gain Is Not Telling You
May 07Here's Why Shareholders May Want To Be Cautious With Increasing Medlive Technology Co., Ltd.'s (HKG:2192) CEO Pay Packet
May 01Medlive Technology (HKG:2192) Shareholders Should Be Cautious Despite Solid Earnings
Apr 21Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Apr 09Optimistic Investors Push Medlive Technology Co., Ltd. (HKG:2192) Shares Up 26% But Growth Is Lacking
Feb 12Should You Be Adding Medlive Technology (HKG:2192) To Your Watchlist Today?
Jan 06Be Wary Of Medlive Technology (HKG:2192) And Its Returns On Capital
Dec 04Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings
Oct 02Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now
Sep 27Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Jul 04Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price
Apr 08Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Feb 20Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?
Jan 10Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price
Sep 27Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Jul 10Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless
May 11Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)
May 02Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 26Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital
Feb 06There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital
Oct 31Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Jul 14These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts
Apr 03Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?
Feb 22Financial Position Analysis
Short Term Liabilities: 2192's short term assets (CN¥3.8B) exceed its short term liabilities (CN¥185.0M).
Long Term Liabilities: 2192's short term assets (CN¥3.8B) exceed its long term liabilities (CN¥28.8M).
Debt to Equity History and Analysis
Debt Level: 2192 is debt free.
Reducing Debt: 2192 had no debt 5 years ago.
Debt Coverage: 2192 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 2192 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/16 17:13 |
| End of Day Share Price | 2026/02/16 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medlive Technology Co., Ltd. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xipeng Feng | China International Capital Corporation Limited |
| Shuo Song | Citic Securities Co., Ltd. |
| Luoxin Jiang | Citic Securities Co., Ltd. |